SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Nifty50 Shariah Companies

BSE Sensex 76664.21
999.79 (-1.29%)

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

Nifty50 Shariah companies as on Apr-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Trent Ltd	Q V PT	4,301	1.24%	1,52,908 Large Cap	6,259 30 Jun, 25	3,276 30 Mar, 26	27.52	77.70	19.85	38.12	39.30	58.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Nestle India Ltd	Q V PT	1,421	0.78%	2,74,023 Large Cap	1,431 24 Apr, 26	1,085 14 Aug, 25	83.65	77.31	51.61	51.01	10.31	9.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Hindalco Industries Ltd	Q V PT	1,048	0.65%	2,35,554 Large Cap	1,054 24 Apr, 26	602 09 May, 25	14.35	14.65	1.72	8.16	15.08	32.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Tata Motors Passenger Vehicles Ltd	Q V+ PT	350	-0.48%	1,28,977 Large Cap	744 11 Jun, 25	294 30 Mar, 26	22.59	1.52	1.20	4.92	10.99	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Oil & Natural Gas Corporation Ltd	Q V+ PT	285	-0.51%	3,58,223 Large Cap	293 02 Mar, 26	226 09 May, 25	11.60	10.96	1.04	4.56	6.84	14.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Max Healthcare Institute Ltd	Q V PT	999	-0.76%	97,256 Mid Cap	1,314 04 Jul, 25	904 07 Apr, 26	12.68	68.53	9.39	43.07	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Cipla Ltd	Q V PT	1,295	-0.85%	1,04,588 Large Cap	1,672 23 Oct, 25	1,166 02 Apr, 26	17.79	23.00	3.11	13.87	9.97	30.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Tata Consumer Products Ltd	Q V PT	1,174	-0.95%	1,16,160 Large Cap	1,221 07 Jan, 26	1,007 02 Apr, 26	7.11	79.12	5.61	41.74	12.82	19.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Ultratech Cement Ltd	Q V PT	12,011	-1.13%	3,53,924 Large Cap	13,104 10 Feb, 26	10,329 23 Mar, 26	8.98	46.17	4.80	22.66	12.35	0.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Dr. Reddys Laboratories Ltd	Q V PT	1,316	-1.29%	1,09,828 Mid Cap	1,378 12 Jun, 25	1,121 07 May, 25	17.66	19.72	2.95	11.85	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Asian Paints Ltd	Q V PT	2,484	-1.51%	2,38,298 Large Cap	2,986 04 Dec, 25	2,116 23 Mar, 26	20.48	61.97	11.58	34.19	10.90	7.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Hindustan Unilever Ltd	Q V PT	2,329	-1.55%	5,47,220 Large Cap	2,780 04 Sep, 25	2,023 02 Apr, 26	20.55	37.71	10.76	34.68	9.67	7.13	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Sun Pharmaceutical Industries Ltd	Q V PT	1,620	-3.57%	3,88,680 Large Cap	1,851 02 May, 25	1,547 26 Sep, 25	16.60	35.61	4.79	19.43	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Tech Mahindra Ltd	Q V PT	1,360	-4.25%	1,33,263 Large Cap	1,850 03 Feb, 26	1,304 09 Mar, 26	14.52	27.70	4.49	14.14	7.52	1.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Tata Consultancy Services Ltd	Q V+ PT	2,397	-4.97%	8,67,364 Large Cap	3,630 12 May, 25	2,346 30 Mar, 26	50.82	17.63	8.08	11.13	10.22	9.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	HCL Technologies Ltd	Q V PT	1,203	-5.79%	3,26,522 Large Cap	1,770 03 Feb, 26	1,199 24 Apr, 26	25.13	19.62	4.34	10.72	10.62	9.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Infosys Ltd	Q V+ PT	1,154	-7.09%	4,68,201 Large Cap	1,728 03 Feb, 26	1,152 24 Apr, 26	28.85	15.90	5.04	9.57	12.41	10.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Nifty50 Shariah - Today's Top Gainers

Company Name	CMP	Price Change(%)
Trent	4,301.35	1.24%
Nestle	1,421.05	0.78%
Hindalco	1,048.20	0.65%

Nifty50 Shariah - Today's Top Losers

Company Name	CMP	Price Change(%)
Infosys	1,154.45	-7.09%
HCL Tech.	1,203.25	-5.79%
TCS	2,397.30	-4.97%
Tech Mahindra	1,360.05	-4.25%
Sun Pharma Inds.	1,619.95	-3.57%

News about Nifty50 Shariah

Apr, 2026

Infosys declines despite its consolidated net profit grows 21% in Q4

The total consolidated income of the company increased by 12.93% at Rs 47,561 crore for Q4FY26

Apr, 2026

Dr. Reddy’s Laboratories informs about clarification on news item

With reference to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) regarding a news item appearing in ‘https://www.cnbctv18.com/’dated April 23, 2026 captioned ‘Dr. Reddy's Laboratories still awaiting approval for a major near-term trigger, sources say’. In this connection, Dr. Reddy’s Laboratories has informed that the above captioned news item headline is correct, as the Company has not yet received approval (‘Notice of Compliance’) for its Semaglutide Injection from Health Canada. Further it has informed that as part of the regulatory review process, the Company has received the ‘Drug Identification Numbers (DINs)’ for Semaglutide Injection from Health Canada on April 22, 2026. The company continue to engage constructively with the regulatory authority and remain committed to bringing the product to the Canadian market upon approval. In compliance with Regulation 30 of the SEBI Listing Regulations, the Company makes prompt disclosures, as and when any event or information is considered material or warrants such disclosure under the said Regulations. The company has informed that at this stage there is no material event/ information that requires disclosure under Regulation 30 of the SEBI Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

Infosys - Quaterly Results

The Revenue for the quarter ended March 2026 of Rs. 386410.00 millions grew by 13.20 % from Rs. 341360.00 millions.Net profit stood at Rs. 79750.00 millions compared to Rs. 66280.00 millions in the corresponding previous quarter,high by 20.32%.The company reported a good operating profit of 106110.00 millions compared to 97020.00 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	386410.00	341360.00	13.20	1488190.00	1365920.00	8.95	1488190.00	1365920.00	8.95
Other Income	10630.00	13230.00	-19.65	64910.00	47820.00	35.74	64910.00	47820.00	35.74
PBIDT	106110.00	97020.00	9.37	425040.00	382810.00	11.03	425040.00	382810.00	11.03
Interest	540.00	510.00	5.88	2070.00	2210.00	-6.33	2070.00	2210.00	-6.33
PBDT	105570.00	96510.00	9.39	411510.00	380600.00	8.12	411510.00	380600.00	8.12
Depreciation	6010.00	5900.00	1.86	23940.00	26190.00	-8.59	23940.00	26190.00	-8.59
PBT	99560.00	90610.00	9.88	387570.00	354410.00	9.36	387570.00	354410.00	9.36
TAX	19810.00	24330.00	-18.58	95460.00	98730.00	-3.31	95460.00	98730.00	-3.31
Deferred Tax	-1380.00	250.00	-652.00	-9130.00	-9630.00	-5.19	-9130.00	-9630.00	-5.19
PAT	79750.00	66280.00	20.32	292110.00	255680.00	14.25	292110.00	255680.00	14.25
Equity	20270.00	20760.00	-2.36	20270.00	20760.00	-2.36	20270.00	20760.00	-2.36
PBIDTM(%)	27.46	28.42	-3.38	28.56	28.03	1.91	28.56	28.03	1.91

Apr, 2026

Infosys’ consolidated net profit grows 21% in Q4

The total consolidated income of the company increased by 12.93% at Rs 47,561 crore for Q4FY26

Apr, 2026

Tech Mahindra informs about newspaper publication

Pursuant to Regulation 30 and Regulation 47 of the SEBI Listing Regulations, Tech Mahindra has enclosed copies of newspaper publication dated 22nd April 2026 of the Audited Consolidated and Standalone Financial Results of the Company for the fourth quarter and financial year ended 31st March 2026, published today, 23rd April 2026 in Financial Express (English) and Loksatta (Marathi). The advertisement also includes a Quick Response code and the weblink to access complete Financial Results for the said period. This intimation is also being uploaded on the website of the Company at the weblink: https://www.techmahindra.com/investors/

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

Tech Mahindra opens communications experience center in Pune

The company has established CEC in Pune to drive AI led innovation for CSPs

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

All Indices

Broad Based Indices:

Nifty 50 Nifty Next 50 Nifty 100 Nifty 200 Nifty Total Market Nifty 500 Nifty Midcap 150 Nifty Midcap 50 Nifty Midcap Select Nifty Midcap 100 Nifty Smallcap 250 Nifty Smallcap 50 NIFTY Smallcap 100 Nifty Microcap 250 Nifty Largemidcap 250 Nifty500 Multicap 50:25:25

Sectoral Indices:

Nifty Auto Nifty Bank Nifty Healthcare Nifty IT Nifty Financial Services Nifty Media Nifty Metal Nifty Pharma Nifty Private Bank Nifty PSU Bank Nifty Realty Nifty Consumer Durables Nifty Oil & Gas Nifty Financial Services 25/50 Nifty Financial Services Ex Bank Nifty FMCG

Thematic Indices:

Nifty Aditya Birla Group Nifty Core Housing Nifty Commodities Nifty CPSE Nifty Financial Services Nifty Energy Nifty Housing Nifty India Consumption Nifty India Defence Nifty India Digital Nifty India Manufacturing Nifty Infrastructure Nifty Mahindra Group Nifty Midcap Liquid 15 Nifty MNC Nifty Mobility Nifty PSE Nifty Non-cyclical Consumer Nifty Services Sector Nifty Shariah 25 Nifty Tata Group Nifty Tata Group 25% Cap Nifty Transportation & Logistics Nifty100 Liquid 15 Nifty50 Shariah Nifty500 Shariah NIFTY SME EMERGE Nifty100 Esg NIFTY100 Enhanced ESG Nifty100 ESG Sector Leaders

Strategy Indices:

Nifty100 Equal Weight Nifty100 Low Volatility 30 Nifty 50 Arbitrage Nifty200 Momentum 30 NIFTY100 Alpha 30 Nifty Alpha 50 Nifty Alpha Low-volatility 30 Nifty Alpha Quality Low-volatility 30 Nifty Alpha Quality Value Low-volatility 30 Nifty Growth Sectors 15 Nifty High Beta 50 NIFTY100 Quality 30 NIFTY Midcap150 Quality 50 Nifty Quality Low Volatility 30 Nifty50 Dividend Points Nifty50 Equal Weight Nifty50 Value 20 Nifty500 Value 50 Nifty200 Quality 30

Nifty50 Shariah FAQs

You can use different criterias to arrive at the list of best stocks in the Nifty50 Shariah company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty50 Shariah companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Nestle India Ltd. (L)	Very Good	1,421	2,74,023	77.31	51.61	51.01	83.65
Tata Consultancy Services Ltd. (L)	Very Good	2,397	8,67,364	17.63	8.08	11.13	50.82
Infosys Ltd. (L)	Very Good	1,154	4,68,201	15.90	5.04	9.57	28.85
Trent Ltd. (L)	Very Good	4,301	1,52,908	77.70	19.85	38.12	27.52
HCL Technologies Ltd. (L)	Very Good	1,203	3,26,522	19.62	4.34	10.72	25.13

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Hindalco Industries Ltd. (L)	Somewhat Good	1,048	2,35,554	66.79
Nestle India Ltd. (L)	Very Good	1,421	2,74,023	16.73
Oil & Natural Gas Corporation Ltd. (L)	Very Good	285	3,58,223	14.20
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,316	1,09,828	9.52
Tata Consumer Products Ltd. (L)	Somewhat Good	1,174	1,16,160	1.15
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Max Healthcare Institute Ltd. (M)	N/A	999	97,256	68.53	9.39	43.07	46.01
Trent Ltd. (L)	Very Good	4,301	1,52,908	77.70	19.85	38.12	39.30
Hindalco Industries Ltd. (L)	Somewhat Good	1,048	2,35,554	14.65	1.72	8.16	15.08
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,316	1,09,828	19.72	2.95	11.85	13.26
Tata Consumer Products Ltd. (L)	Somewhat Good	1,174	1,16,160	79.12	5.61	41.74	12.82

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Max Healthcare Institute Ltd. (M)	N/A	999	97,256	68.53	9.39	43.07	60.18
Trent Ltd. (L)	Very Good	4,301	1,52,908	77.70	19.85	38.12	58.73
Hindalco Industries Ltd. (L)	Somewhat Good	1,048	2,35,554	14.65	1.72	8.16	32.50
Cipla Ltd. (L)	Very Good	1,295	1,04,588	23.00	3.11	13.87	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,620	3,88,680	35.61	4.79	19.43	23.50

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Nifty50 Shariah Companies

News about Nifty50 Shariah

Infosys declines despite its consolidated net profit grows 21% in Q4

Dr. Reddy’s Laboratories informs about clarification on news item

Infosys - Quaterly Results

Infosys’ consolidated net profit grows 21% in Q4

Tech Mahindra informs about newspaper publication

Tech Mahindra opens communications experience center in Pune